does caresource cover semaglutide Wegovy Weight Loss Injections & Clinics Near You Megan Lieu • Tech &
Description
injection, dual-compound options, or microdose protocols) that better suit your biology
Patient advocacy and healthcare provider support also influence coverage timelines
Semaglutide is a GLP-1 receptor agonist that increases insulin secretion in response to glucose, suppresses glucagon, and reduces appetite signaling in the brain
The result is reduced calorie intake without conscious restriction, making sustainable weight loss achievable for many non-diabetic patients
However, these compounded versions are not FDA-approved and may carry additional risks depending on where and how theyre made
